Infection and cancer: Biology, therapeutics and prevention

Abstract

This meeting has provided a timely overview of the recent advances and ongoing challenges in the translational research of infection-associated cancers. The development of primary preventive vaccines and therapeutic vaccines for cervical cancers. and immunotherapy against EBV-associated cancers have shown great promise and warrant further evaluation. Novel population-based screening strategies should be evaluated prospectively for NPC and gastric cancer. © 2009 Future Medicine Ltd.